E2F1 and gastric cancer: In summary, our results indicated that the mRNA levels of E2F1/2/3/5/8 were significantly increased in both GC tissues and cell lines compared with those in the control samples, which mainly resulted from gene amplification and were associated with the clinical outcomes of GC patients.